Daniel Ries

Pharmacokinetics of bempedoic acid in patients with renal impairment

Benny Amore, William J. Sasiela, Daniel Ries et al. · Clinical and Translational Science · 2021 · 31 citations · Full text

Urology, Renal Function, Medicine +15

P0712 : The pharmacokinetics of GS-5816, a pangenotypic HCV-specific NS5A inhibitor, in HCV-uninfected subjects with severe renal impairment

Erik Mogalian, Anita Mathias, Diana M. Brainard et al. · Journal of Hepatology · 2015 · 18 citations

Severe Renal Impairment, Hcv-uninfected Subjects, Viral Hepatitis +9

Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney Disease

Detlef Albrecht, Mintu P. Turakhia, Daniel Ries et al. · Thrombosis and Haemostasis · 2017 · 17 citations

NaPi-IIb Inhibition for Hyperphosphatemia in CKD Hemodialysis Patients

S Maruyama, Thomas Marbury, Jeffrey J. Connaire et al. · Kidney International Reports · 2020 · 14 citations · Full text